Palette Life Sciences Announces FDA 510(k) Clearance for Barrigel® Rectal Spacer, Proven Safe and Effective at Minimizing the Harmful Long-Term Side Effects of Prostate Radiation Therapy - Palette Life Sciences
By A Mystery Man Writer
Groundbreaking technology introduces increased control to achieve optimal coverage proven to significantly reduce the risk of toxicity to the rectum SANTA BARBARA, CALIF. / STOCKHOLM, SWEDEN – June 9, 2022— Palette Life Sciences, a fully-integrated global life sciences company dedicated to improving patient outcomes, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of […]
MINIMIZE THE SIDE EFFECTS
Barrigel® Rectal Spacing
James Leech on LinkedIn: Palette Life Sciences Announces FDA 510(k
Frontiers Planning With Patient-Specific Rectal Sub-Region
Radiation Therapy
Barrigel Patient Resource Center
Helena Jansson på LinkedIn: Palette Life Sciences Announces FDA
FDA OKs Palette Life Sciences' Barrigel Rectal Spacer
Frontiers A novel hydrogel orthotopic injection model in
SpaceOAR - Augmenix, Boston Scientific, and Conflicts of Interest
Barrigel on LinkedIn: Palette Life Sciences Announces FDA 510(k
Prostate Cancer Radiation Therapy Recommendations in Response to
Rectal Spacer - Urologist in Syracuse, NY, BPH, ED, Prostate
